AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 37516844 — intervention group
Group type: EXPERIMENTAL
Intervention: Family intervention with Brazilian‐adapted Planetary Healthy Diet (PHD), reduced portion sizes, increased physical activity, reduced sedentary behavior, and reduced sodium salt plus anti‐inflammatory herbs.
Number of subjects: 0
Study 37516844 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving a print of the Brazilian dietary guideline.
Number of subjects: 0
Study 34482657 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive program (education regarding breast cancer; progressive muscle relaxation; stress management; emotional coping; problem-solving strategies)
Number of subjects: 60
Study 34482657 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive program
Number of subjects: 60
Study 34482657 — intervention group
Group type: COMPARATOR
Intervention: Control group (no supportive program)
Number of subjects: 60
Study 33571957 — intervention group
Group type: COMPARATOR
Intervention: N20 (20-minute nap opportunity)
Number of subjects: 9
Study 33571957 — intervention group
Group type: COMPARATOR
Intervention: CAF (5 mg·kg‐1 caffeine)
Number of subjects: 9
Study 33571957 — intervention group
Group type: COMPARATOR
Intervention: CAF+N (caffeine before N20)
Number of subjects: 9
Study 32996442 — intervention group
Group type: EXPERIMENTAL
Intervention: Housing First (HF) program with Assertive Community Treatment team support
Number of subjects: 703
Study 32996442 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 703
Study 34962595 — intervention group
Group type: EXPERIMENTAL
Intervention: Algorithm in the time domain
Number of subjects: 13
Study 34962595 — intervention group
Group type: COMPARATOR
Intervention: Both algorithms
Number of subjects: 13
Study 34962595 — intervention group
Group type: EXPERIMENTAL
Intervention: PRBS testing
Number of subjects: 13
Study 34962595 — intervention group
Group type: EXPERIMENTAL
Intervention: Incrementally increasing exercise intensities
Number of subjects: 13
Study 34068235 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (INT) - Action Schools! BC program (16 schools, 747 students)
Number of subjects: 1529
Study 34068235 — intervention group
Group type: COMPARATOR
Intervention: Control (UP) - Usual practice (14 schools, 782 students)
Number of subjects: 1529
Study 33295307 — intervention group
Group type: EXPERIMENTAL
Intervention: Large Jejunal Incision (LJI)
Number of subjects: 48
Study 33295307 — intervention group
Group type: COMPARATOR
Intervention: Small Jejunal Incision (SJI)
Number of subjects: 48
Study 36239367 — intervention group
Group type: COMPARATOR
Intervention: L0% (no load)
Number of subjects: 12
Study 36239367 — intervention group
Group type: EXPERIMENTAL
Intervention: L10% (10% of body weight)
Number of subjects: 12
Study 36239367 — intervention group
Group type: EXPERIMENTAL
Intervention: L20% (20% of body weight)
Number of subjects: 12
Study 36239367 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of NL and DL during L10%
Number of subjects: 12
Study 36239367 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of NL and DL during L0%
Number of subjects: 12
Study 33156289 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Molecular-Weight Heparin (LMWH)
Number of subjects: 20341
Study 33156289 — intervention group
Group type: COMPARATOR
Intervention: Unfractionated Heparin (UH)
Number of subjects: 20341
Study 33423021 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-led creative writing workshop (CWW)
Number of subjects: 60
Study 33423021 — intervention group
Group type: COMPARATOR
Intervention: Active control (AC)
Number of subjects: 60
Study 33449418 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessment plus computer-generated individualized feedback letters at baseline and months 3 and 6
Number of subjects: 1646
Study 33449418 — intervention group
Group type: COMPARATOR
Intervention: Assessment only
Number of subjects: 1646
Study 32761191 — intervention group
Group type: COMPARATOR
Intervention: Ketogenic Diet (KD)
Number of subjects: 158
Study 32761191 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Atkins Diet (MAD)
Number of subjects: 158
Study 32761191 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Glycemic Index Therapy Diet (LGIT)
Number of subjects: 158
Study 32761191 — intervention group
Group type: COMPARATOR
Intervention: Ketogenic Diet (KD) vs Modified Atkins Diet (MAD)
Number of subjects: 158
Study 32761191 — intervention group
Group type: COMPARATOR
Intervention: Ketogenic Diet (KD) vs Low Glycemic Index Therapy Diet (LGIT)
Number of subjects: 158
Study 35059305 — intervention group
Group type: EXPERIMENTAL
Intervention: Chatbot therapy (n = 41)
Number of subjects: 83
Study 35059305 — intervention group
Group type: COMPARATOR
Intervention: Bibliotherapy (n = 42)
Number of subjects: 83
Study 34637414 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild therapeutic hypothermia (32.0-34.0°C)
Number of subjects: 459
Study 34637414 — intervention group
Group type: COMPARATOR
Intervention: Targeted normothermia (36.0-37.0°C)
Number of subjects: 459
Study 34845002 — intervention group
Group type: EXPERIMENTAL
Intervention: Erenumab 140 mg monthly
Number of subjects: 240
Study 34845002 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study 34008856 — intervention group
Group type: EXPERIMENTAL
Intervention: Astragalus polysaccharide (APS) at concentrations of 40, 100, or 400 μg/mL
Number of subjects: 0
Study 34008856 — intervention group
Group type: COMPARATOR
Intervention: Control group (Ctrl group)
Number of subjects: 0
Study 34008856 — intervention group
Group type: COMPARATOR
Intervention: FA-treated cells (FA group, 120 μmol/L)
Number of subjects: 0
Study 34008856 — intervention group
Group type: EXPERIMENTAL
Intervention: FA + APS groups (with APS concentrations)
Number of subjects: 0
Study 33499027 — intervention group
Group type: EXPERIMENTAL
Intervention: COVID-19-related quarantine
Number of subjects: 359
Study 34510196 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory Training (AT)
Number of subjects: 147
Study 34510196 — intervention group
Group type: COMPARATOR
Intervention: Control Condition (Computer Games - CG)
Number of subjects: 147
Study 32297373 — intervention group
Group type: EXPERIMENTAL
Intervention: 5As model of brief intervention (ask, advise, assess, assist, arrange)
Number of subjects: 1047
Study 34798201 — intervention group
Group type: EXPERIMENTAL
Intervention: Guselkumab
Number of subjects: 1721
Study 34403780 — intervention group
Group type: EXPERIMENTAL
Intervention: eatNplay group videoconferencing telehealth sessions
Number of subjects: 44
Study 34403780 — intervention group
Group type: COMPARATOR
Intervention: Monthly newsletters
Number of subjects: 44
Study 32343261 — intervention group
Group type: EXPERIMENTAL
Intervention: Male
Number of subjects: 222
Study 32343261 — intervention group
Group type: EXPERIMENTAL
Intervention: Female
Number of subjects: 222
Study 32343261 — intervention group
Group type: EXPERIMENTAL
Intervention: Both genders
Number of subjects: 222
Study 34845352 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin (Epo)
Number of subjects: 750
Study 34845352 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 750
Study 33050833 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone (mu-opioid blocker)
Number of subjects: 0
Study 33050833 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35665745 — intervention group
Group type: EXPERIMENTAL
Intervention: NVSI-06-07
Number of subjects: 1800
Study 35665745 — intervention group
Group type: COMPARATOR
Intervention: BBIBP-CorV
Number of subjects: 1800
Study 32032997 — intervention group
Group type: EXPERIMENTAL
Intervention: DieTBra (traditional Brazilian diet)
Number of subjects: 111
Study 32032997 — intervention group
Group type: EXPERIMENTAL
Intervention: Olive oil (52 mL/day)
Number of subjects: 111
Study 35505631 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjusted motor IFC
Number of subjects: 102
Study 35505631 — intervention group
Group type: COMPARATOR
Intervention: Placebo IFC
Number of subjects: 102
Study 33677837 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-drinking comments
Number of subjects: 723
Study 33677837 — intervention group
Group type: EXPERIMENTAL
Intervention: Warning labels
Number of subjects: 723
Study 33677837 — intervention group
Group type: EXPERIMENTAL
Intervention: Pro-drinking comments
Number of subjects: 723
Study 33677837 — intervention group
Group type: EXPERIMENTAL
Intervention: Industry responsibility messages
Number of subjects: 723
Study 32462921 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin II as an add-on vasopressor
Number of subjects: 0
Study 32462921 — intervention group
Group type: COMPARATOR
Intervention: Norepinephrine as first-line vasopressor
Number of subjects: 0
Study 34814232 — intervention group
Group type: EXPERIMENTAL
Intervention: Black myrobalan (500 mg capsules, six capsules per day for 4 weeks)
Number of subjects: 0
Study 34814232 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32784117 — intervention group
Group type: EXPERIMENTAL
Intervention: Idebenone
Number of subjects: 28
Study 32784117 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 35975297 — intervention group
Group type: EXPERIMENTAL
Intervention: CMV IgG titer
Number of subjects: 672
Study 33517683 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive blood pressure lowering (systolic BP <120 mm Hg)
Number of subjects: 9286
Study 33517683 — intervention group
Group type: COMPARATOR
Intervention: Standard blood pressure treatment
Number of subjects: 9286
Study 34879226 — intervention group
Group type: EXPERIMENTAL
Intervention: Edoxaban
Number of subjects: 60
Study 34879226 — intervention group
Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 60
Study 34879226 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study 33372830 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-Stranded Tag Hybridization Chromatographic Printed-Array Strip (STH-PAS) method
Number of subjects: 378
Study 36073737 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional $40 per month in fruit and vegetable benefits for WIC participants
Number of subjects: 0
Study 36073737 — intervention group
Group type: COMPARATOR
Intervention: Standard WIC benefits (control group)
Number of subjects: 0
Study 33002318 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise-induced bronchoconstriction (EIB) test
Number of subjects: 367
Study 33002318 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous laryngoscopy exercise (CLE) test
Number of subjects: 367
Study 34811505 — intervention group
Group type: EXPERIMENTAL
Intervention: ctDNA positive patients
Number of subjects: 354
Study 34811505 — intervention group
Group type: COMPARATOR
Intervention: ctDNA negative patients
Number of subjects: 354
Study 34811505 — intervention group
Group type: EXPERIMENTAL
Intervention: ctDNA status (positive vs negative)
Number of subjects: 354
Study 34811505 — intervention group
Group type: EXPERIMENTAL
Intervention: ctDNA as a prognostic marker
Number of subjects: 354
Study 35800975 — intervention group
Group type: EXPERIMENTAL
Intervention: Active meditation program (once a week for three months)
Number of subjects: 22
Study 35800975 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 22
Study 32940679 — intervention group
Group type: COMPARATOR
Intervention: Standard recumbent bike for 15 to 20 minutes each session (Control)
Number of subjects: 386
Study 32940679 — intervention group
Group type: EXPERIMENTAL
Intervention: Body weight‐adjustable treadmill for 15 to 20 minutes each session
Number of subjects: 386
Study 32940679 — intervention group
Group type: EXPERIMENTAL
Intervention: Patterned electrical neuromuscular stimulation device for 15 to 20 minutes each session
Number of subjects: 386
Study 32940679 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of the treadmill and electrical neuromuscular stimulation for 15 to 20 minutes each session
Number of subjects: 386
Study 34948828 — intervention group
Group type: EXPERIMENTAL
Intervention: PrepCheck® (PC)
Number of subjects: 97
Study 34948828 — intervention group
Group type: EXPERIMENTAL
Intervention: Dental Teacher™ (DT)
Number of subjects: 97
Study 34948828 — intervention group
Group type: COMPARATOR
Intervention: Faculty Feedback (FF)
Number of subjects: 97
Study 35257386 — intervention group
Group type: EXPERIMENTAL
Intervention: Tree Theme Method (TTM)
Number of subjects: 118
Study 35257386 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (control)
Number of subjects: 118
Study 32375741 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated pediatric TB services into child healthcare services, consisting of training, supportive supervision, job aids, and logistical support.
Number of subjects: 0
Study 32375741 — intervention group
Group type: COMPARATOR
Intervention: Standard of care offering pediatric TB services based on national standard of care.
Number of subjects: 0
Study 32375741 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated pediatric TB services into child healthcare services.
Number of subjects: 0
Study 33289598 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous antibiotic prophylaxis
Number of subjects: 607
Study 33289598 — intervention group
Group type: COMPARATOR
Intervention: Control (not receiving continuous antibiotic prophylaxis as per model recommendation)
Number of subjects: 607
Study 32384885 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-h training involving 10 written clinical cases (experimental)
Number of subjects: 87
Study 32384885 — intervention group
Group type: COMPARATOR
Intervention: 1-h lecture and 1-h outpatient clinic (lecture)
Number of subjects: 87
Study 32384885 — intervention group
Group type: COMPARATOR
Intervention: 2-h outpatient clinic (no intervention)
Number of subjects: 87
Study 34083231 — intervention group
Group type: EXPERIMENTAL
Intervention: Once‐every‐3‐weeks cisplatin at 100 mg/m2 for two cycles
Number of subjects: 510
Study 34083231 — intervention group
Group type: COMPARATOR
Intervention: Once‐a‐week cisplatin at 40 mg/m2 for six cycles
Number of subjects: 510
Study 34083231 — intervention group
Group type: EXPERIMENTAL
Intervention: Once‐every‐3‐weeks cisplatin
Number of subjects: 510
Study 34083231 — intervention group
Group type: COMPARATOR
Intervention: Once‐a‐week cisplatin
Number of subjects: 510
Study 33899624 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced Milieu Teaching with Phonological Emphasis (EMT+PE)
Number of subjects: 24
Study 33899624 — intervention group
Group type: COMPARATOR
Intervention: Business-as-usual (BAU)
Number of subjects: 24
Study 36443661 — intervention group
Group type: EXPERIMENTAL
Intervention: WBV alone
Number of subjects: 51
Study 36443661 — intervention group
Group type: EXPERIMENTAL
Intervention: WV alone
Number of subjects: 51
Study 36443661 — intervention group
Group type: EXPERIMENTAL
Intervention: WBV + WV
Number of subjects: 51
Study 33905482 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperthermia at 44C
Number of subjects: 53
Study 33905482 — intervention group
Group type: COMPARATOR
Intervention: Control (37C)
Number of subjects: 53
Study 32178633 — intervention group
Group type: EXPERIMENTAL
Intervention: On The Move (OTM) group-exercise program
Number of subjects: 248
Study 32178633 — intervention group
Group type: COMPARATOR
Intervention: Seated exercise program (usual-care)
Number of subjects: 248
Study 34759131 — intervention group
Group type: EXPERIMENTAL
Intervention: DCB
Number of subjects: 184
Study 34759131 — intervention group
Group type: COMPARATOR
Intervention: DES
Number of subjects: 184
Study 34714211 — intervention group
Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass (RYGB)
Number of subjects: 17
Study 34714211 — intervention group
Group type: EXPERIMENTAL
Intervention: One-anastomosis gastric bypass (OAGB)
Number of subjects: 17
Study 34542017 — intervention group
Group type: EXPERIMENTAL
Intervention: Bio-banded (BB) competition
Number of subjects: 65
Study 34542017 — intervention group
Group type: COMPARATOR
Intervention: Chronological age (CA) competition
Number of subjects: 65
Study 33838758 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam
Number of subjects: 520
Study 33838758 — intervention group
Group type: COMPARATOR
Intervention: Valproate
Number of subjects: 520
Study 35266898 — intervention group
Group type: EXPERIMENTAL
Intervention: Animation and gamification in online distance education
Number of subjects: 70
Study 35266898 — intervention group
Group type: COMPARATOR
Intervention: Control group (no animation and gamification)
Number of subjects: 70
Study 32396519 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib 5 or 10 mg twice daily
Number of subjects: 3330
Study 32396519 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3330
Study 33276036 — intervention group
Group type: EXPERIMENTAL
Intervention: Synchronous tACS (55 Hz enveloped by 6 Hz)
Number of subjects: 45
Study 33276036 — intervention group
Group type: EXPERIMENTAL
Intervention: Desynchronous tACS (55 Hz enveloped by 6 Hz)
Number of subjects: 45
Study 33276036 — intervention group
Group type: COMPARATOR
Intervention: Sham tACS
Number of subjects: 45
Study 32214299 — intervention group
Group type: EXPERIMENTAL
Intervention: Paramedian approach of lumbar epidural injection (LEI)
Number of subjects: 104
Study 32214299 — intervention group
Group type: COMPARATOR
Intervention: Midline approach of lumbar epidural injection (LEI)
Number of subjects: 104
Study 36192937 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive condition (engaging sensory task)
Number of subjects: 59
Study 33688090 — intervention group
Group type: EXPERIMENTAL
Intervention: Open suction systems (OSS)
Number of subjects: 66
Study 33688090 — intervention group
Group type: COMPARATOR
Intervention: Closed suction systems (CSS)
Number of subjects: 66
Study 32883724 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent intervention to improve adherence to cardiac rehabilitation (CR) and cardiovascular medications.
Number of subjects: 31
Study 35718871 — intervention group
Group type: EXPERIMENTAL
Intervention: n‐3 PUFA supplementation
Number of subjects: 782
Study 33860790 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (n = 42)
Number of subjects: 87
Study 33860790 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 45)
Number of subjects: 87
Study 34359017 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese Metacognitions about Smartphone Use Questionnaire (Chinese MSUQ)
Number of subjects: 698
Study 34569334 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous injection of 2 g tranexamic acid (TXA) and local use of 1 g intraoperatively (Group B)
Number of subjects: 0
Study 34569334 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of 2 g tranexamic acid (TXA) and 10 mg rivaroxaban qd treatment postoperatively (Group C)
Number of subjects: 0
Study 34569334 — intervention group
Group type: COMPARATOR
Intervention: 0.9% NaCl solution intravenously (Group A)
Number of subjects: 0
Study 34380473 — intervention group
Group type: EXPERIMENTAL
Intervention: Piezo-surgery
Number of subjects: 80
Study 34380473 — intervention group
Group type: EXPERIMENTAL
Intervention: Piezo-surgery with 8 mg dexamethasone
Number of subjects: 80
Study 34380473 — intervention group
Group type: EXPERIMENTAL
Intervention: Piezo-surgery without dexamethasone
Number of subjects: 80
Study 34380473 — intervention group
Group type: COMPARATOR
Intervention: Conventional rotatory without dexamethasone
Number of subjects: 80
Study 34380473 — intervention group
Group type: EXPERIMENTAL
Intervention: Piezo-surgery with dexamethasone
Number of subjects: 80
Study 34380473 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional rotatory with dexamethasone
Number of subjects: 80
Study 32041957 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma levels of 90 neurology-related proteins
Number of subjects: 798
Study 32041957 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI-assessed total brain volume
Number of subjects: 798
Study 32041957 — intervention group
Group type: COMPARATOR
Intervention: Plasma levels of neurology-related proteins in INTERVAL
Number of subjects: 798
Study 35803172 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual bronchodilator therapy with umeclidinium bromide (UMEC)/vilanterol (VI)
Number of subjects: 1000
Study 35803172 — intervention group
Group type: COMPARATOR
Intervention: Monotherapy with umeclidinium bromide (UMEC)
Number of subjects: 1000
Study 35803172 — intervention group
Group type: COMPARATOR
Intervention: Monotherapy with salmeterol (SAL)
Number of subjects: 1000
Study 34489263 — intervention group
Group type: EXPERIMENTAL
Intervention: Shorter, more tolerable regimens of oral drugs
Number of subjects: 0
Study 34489263 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 0
Study 32302083 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-stage BTHA
Number of subjects: 195
Study 32302083 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-stage BTKA
Number of subjects: 195
Study 33942560 — intervention group
Group type: EXPERIMENTAL
Intervention: Atogepant 300 mg
Number of subjects: 60
Study 33942560 — intervention group
Group type: COMPARATOR
Intervention: Moxifloxacin 400 mg
Number of subjects: 60
Study 33942560 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 32348699 — intervention group
Group type: EXPERIMENTAL
Intervention: short-term existential behavioural therapy (sEBT); 2 individual 1-h sessions
Number of subjects: 157
Study 32348699 — intervention group
Group type: COMPARATOR
Intervention: active control
Number of subjects: 157
Study 32348699 — intervention group
Group type: EXPERIMENTAL
Intervention: sEBT or active control
Number of subjects: 157
Study 36189985 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin (10 mg, once daily)
Number of subjects: 11007
Study 36189985 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11007
Study 33128587 — intervention group
Group type: EXPERIMENTAL
Intervention: BPTB with standard rehabilitation
Number of subjects: 160
Study 33128587 — intervention group
Group type: EXPERIMENTAL
Intervention: BPTB with accelerated rehabilitation
Number of subjects: 160
Study 33128587 — intervention group
Group type: EXPERIMENTAL
Intervention: HT with standard rehabilitation
Number of subjects: 160
Study 33128587 — intervention group
Group type: EXPERIMENTAL
Intervention: HT with accelerated rehabilitation
Number of subjects: 160
Study 32402953 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group (36 weeks swimming program, 3 sessions per week)
Number of subjects: 45
Study 32402953 — intervention group
Group type: COMPARATOR
Intervention: Control group (recreational swimming program, 2 sessions per week for 36 weeks)
Number of subjects: 45
Study 33784898 — intervention group
Group type: EXPERIMENTAL
Intervention: Plan A (entertainment-education video intervention)
Number of subjects: 242